Author:
Damber J. -E.,Daehlin L.,Tomic R.,Nilsson T. K.
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Veterans Administration’s Cooperative Urological Research Group. Carcinoma of the prostate: Treatment comparison.J. Urol., 98, 516 (1967).
2. Bailar, J. C., Byar, D. P.: Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo.Cancer, 26, 257 (1970).
3. Hedlund, P. O., Gustafson, H., Sjögren, S.: Cardiovascular complications to treatment of prostate cancer with estramustine phosphate or conventional estrogen.Scand. J. Urol. Nephrol., 55, 103 (1980).
4. Büller, H. R., Boon, T. A., Henny, C. P., Dabhoiwala, N. F., Ten Cate J. W.: Estrogen-induced deficiency and decrease in antithrombin III activity in patients with prostatic cancer.J. Urol., 128, 72 (1982).
5. Agardh, C.-D., Nilsson-Ehle, P., Lundgren, R., Gustavsson, A.: The influence of treatment with estrogens and estramustine phosphate on platelet aggregation and plasma lipoproteins in non-disseminated prostatic carcinoma.J. Urol., 132, 1021 (1984).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Drug-Induced Alterations of Hemostasis and Fibrinolysis;Hematology/Oncology Clinics of North America;1992-12